Astute Imaging
Astute Imaging provides an AI-powered cloud-based image-guided therapy platform for cardiovascular care, serving healthcare providers and medical device manufacturers with 3D surgery planning, patient tracking, clinical trial imaging, and device performance analytics.
- Company typePrivate
- Founded2021
- HeadquartersKirkland, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Astute Imaging does
Astute Imaging is a privately-held healthcare technology company founded in 2021 and headquartered in Kirkland, Washington, with Delaware incorporation as Astute Imaging, LLC. The company provides an AI-powered cloud-based image-guided therapy platform focused on cardiovascular and interventional radiology applications, spanning the full care continuum—triage, diagnostics, surgery planning, treatment, device recommendation, modeling/simulation, and post-operative follow-up—with native integration into EMR, PACS, and society registries. Astute was carved out of Fivos Health (formerly Medstreaming/M2S) in February 2022, inheriting nearly two decades of cardiovascular imaging software heritage, and was subsequently supplemented by the March 2022 acquisition of DilenyTech to accelerate AI development.
The product portfolio is anchored on three software assets: Preview® (interactive 3D modeling and measurement for pre- and post-operative planning), PEMS® (a cloud-based patient registry and longitudinal tracking platform with multi-tenant device performance databases), and SurveillAAAnce® (post-operative AAA surveillance and alerts). The platform is supported by patented Finite Element Analysis for arteries, 30+ issued and pending patents originating from research at Dartmouth College and MIT Media Lab, and a curated longitudinal data asset of 345,000+ cardiovascular cases, 80+ million images, and 6 million data points drawn from 200+ providers.
Astute generates revenue through three primary streams: SaaS subscriptions to healthcare providers via Preview® and PEMS® (annual, quote-based billing), professional services for medical device manufacturers including imaging core lab work for Pilot, IDE, and post-market surveillance trials, and R&D data services monetizing the multi-tenant database. The go-to-market is direct enterprise field sales targeting two primary segments—healthcare providers (physicians at 2,000+ medical centers) and medical device manufacturers (with named relationships including Cook Medical and Nectero Medical)—supported by clinical application specialists, content marketing, and event participation. The company holds ISO 13485:2016, ISO 27001, HIPAA, and GDPR certifications, supporting both US and EU regulatory pathways.
Astute Imaging firmographics
Firmographics- Name
- Astute Imaging
- Legal name
- Astute Imaging, LLC
- Website
- https://astuteimaging.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Astute Imaging provides an AI-powered cloud-based image-guided therapy platform for cardiovascular care, serving healthcare providers and medical device manufacturers with 3D surgery planning, patient tracking, clinical trial imaging, and device performance analytics.
- Ownership category
- akta.pro rank
Astute Imaging industry classification
Industry- Product category
- Medical Imaging Software
- NAICS
- Computer Systems Design and Related Services (54151)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844)
- akta.pro primary industry
- AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG)
- akta.pro secondary industries
- Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic) (HLACALAD), Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG), Medical Imaging AI (HDAAAEAH), Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity) (HLACABAM), Image Exchange, Sharing & Patient/Provider Portals (DICOM/Web) (HLACALAI)
Keywords
Where Astute Imaging is headquartered
LocationHeadquarters
- HQ city
- Kirkland
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Astute Imaging business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- SaaS Subscription Services: Subscription-based imaging services providing physicians with 24/7 access to pre- and post-surgery planning and follow-up tools including 3D modeling/reconstruction, measurements, analysis, tracking, and alerts management. Tiered access through Preview® and PEMS® platforms.
- Imaging Core Lab Services: Clinical trial image management services for device manufacturers including Pilot, IDE, and post-market surveillance projects. Nearly two decades of experience providing high-quality, cost-effective image management.
- Industry Case Planning Services: Surgery case planning platform for medical device companies providing 3D models, device sizing analysis, and comprehensive reports for building device performance tracking databases.
- R&D Data Services: Research database services providing curated longitudinal data and images for academic research and industry product development. Advanced data mining of multi-tenant database with 6 million data points.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Subscription-based SaaS |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Astute Imaging product offering
Product offeringCore offering
Astute Imaging provides an AI-powered, cloud-based image-guided therapy platform for cardiovascular and interventional radiology procedures. Its core offerings include Preview® for interactive 3D pre-operative planning and measurements, PEMS® for patient registry and longitudinal tracking, and SurveillAAAnce® for post-operative AAA surveillance, complemented by clinical trial imaging core lab services and curated R&D data services for medical device manufacturers.
Product overview
Astute Imaging offers a cloud-based AI-powered image-guided therapy platform consisting of Preview® (interactive 3D surgery planning and measurements), PEMS® (patient registry and tracking with longitudinal analysis), and SurveillAAAnce® (post-op AAA surveillance). The platform provides integrated services including Imaging Core Lab for clinical trials, R&D Data Services for medical device research, and Industry Case Planning for device companies. The company leverages AI for medical imaging analysis, predictive analytics, and workflow automation across cardiovascular, neurology, oncology, and MSK applications. The platform integrates with EMR, PACS, and society registries, processing DICOM images with 24/7 availability for pre- and post-surgery planning.
Differentiator
Problem solved
Functional benefit
Brands
- Preview: Interactive 3D modeling and measurements solution for surgery planning with patented technology for endovascular procedures including AAA, TAA, fenestrated and branched aneurysm repairs.
- PEMS (Patient Evaluation and Management System)
- SurveillAAAnce
- vDAC
Products and services
- Preview® Interactive 3D modeling and measurements solution for cardiovascular surgery planning, providing 120+ measurement protocols, pre- and post-operative planning tools, and C-arm angle predictions for complex endovascular procedures including AAA, TAA, fenestrated and branched aneurysm repairs.
- PEMS® (Patient Evaluation and Management System) Cloud-based patient registry and tracking system offering 24/7 access to anatomical measurements and images, with longitudinal analysis, integrated alerts management, customizable morphology alerts, treatment planning integration with Preview®, and device tracking capabilities for healthcare providers and medical device manufacturers.
- SurveillAAAnce® Low-cost post-operative AAA surveillance and tracking tool providing critical measurements and notifications based on user-set variables, tracking five critical post-operative measurements including total volume of aorta/iliac contents, endoleak volume, maximum aneurysm sac diameter, aortic diameter, and distal renal to stent graft distance.
- Imaging Core Lab Services End-to-end clinical trial image management services for medical device manufacturers supporting Pilot, IDE, and post-market surveillance projects, with 80+ million images processed across 90+ clinical trials, 24-hour processing turnaround, independent radiologist reads, and image data QC and archiving.
- R&D Data Services Research database service providing 20+ years of curated clinical data and images with 350,000+ imaging studies and 6 million data points from 200+ providers, supporting predictive treatment models, personalized care management, and new product development for academic and industry partners.
- Industry Case Planning Surgery case planning platform enabling efficient image-guided surgery planning with 3D models, detailed analysis reports, and device sizing, allowing device companies to build proprietary device databases for performance tracking and usage analysis through PEMS® integration.
Quantifiable outcome
- 45 minutes average time savings per surgery case
- +6 more outcomes
Companies that use Astute Imaging
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Astute Imaging technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature6 records
Astute Imaging partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Nectero MedicalcoreStrategic agreement for Phase II/III clinical trial of Nectero EAST System for treatment of small-to-mid-sized abdominal aortic aneurysms. Astute Imaging provides advanced imaging technologies including Preview® and PEMS® for device tracking and treatment outcome monitoring. Built on prior partnership from Phase I clinical trial outside the US. Astute Imaging's AI-driven image-based RWE platform enables near real-time visibility of implanted device performance.
Scale indicators15 records
Recent moves5 records
Expansion highlights5 records
Astute Imaging competitors and assessment
Company assessmentDirect peers
- HeartFlow: HeartFlow provides AI-driven cardiovascular analysis (FFR-CT) for non-invasive coronary assessment and procedural planning. Like Astute, it serves interventional cardiology with AI-powered image analysis and is closely comparable in clinical workflow and customer base.
- Circle Cardiovascular Imaging: Circle CVI provides post-processing and analysis software for cardiac MR, CT, and other cardiovascular imaging. It is comparable to Astute's Preview® in providing advanced visualization and quantification for cardiovascular procedural planning.
- Pie Medical Imaging: Pie Medical Imaging develops cardiovascular imaging analysis software for CT, MR, and X-ray, including 3D planning and quantification tools. It directly competes with Astute in providing image-based procedure planning for interventional cardiology and vascular workflows.
Emerging players
- RapidAI: RapidAI applies AI to medical imaging for clinical decision-making, initially in stroke but expanding into vascular and other workflows. It is comparable to Astute as an AI imaging vendor targeting procedure planning and post-market outcomes tracking.
- Viz.ai: Viz.ai builds AI-powered care coordination on medical imaging, with workflow software for stroke and cardiovascular triage. Comparable to Astute in combining AI imaging analytics with care-team workflow integration, though focused earlier in the patient pathway.
- Aidoc: Aidoc provides an AI imaging platform for radiology triage and workflow across multiple specialties. It overlaps with Astute in delivering AI orchestration on imaging studies, though with a broader cross-specialty rather than vascular specialty focus.
- Median Technologies: Median Technologies delivers imaging core lab and AI-driven image analysis for oncology clinical trials. It is comparable to Astute's Imaging Core Lab services in supporting device and pharmaceutical trials with regulatory-grade imaging endpoints.
- icometrix: icometrix provides AI-based quantification of medical imaging for neurology and other specialties. It is comparable to Astute in delivering specialty AI imaging analytics on a regulated platform with FDA/CE-cleared software.
Broad incumbents
- TeraRecon (ConcertAI): TeraRecon (now part of ConcertAI) provides advanced visualization and AI imaging analytics for radiology. It is comparable to Astute's Preview® platform for image-guided procedure planning and supports cardiovascular, neurology, and oncology workflows.
- Arterys (Tempus): Arterys (acquired by Tempus) provides cloud-based AI imaging analytics across cardiovascular, oncology, and other specialties. It is comparable to Astute as a cloud-native AI platform for cardiovascular image analysis with clinical and research workflows.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Astute Imaging social profiles
Digital presenceAstute Imaging compliance and trust
Trust signalCompliance4 records
Astute Imaging financial estimates
Financial estimateRevenue estimate
Valuation estimate
Astute Imaging leadership team
Management profileNumber of profiles
Profiles4 records
Astute Imaging subsidiaries and ownership
Company hierarchySubsidiaries1 record
Astute Imaging funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Astute Imaging M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Astute Imaging
What does Astute Imaging do?
Astute Imaging provides an AI-powered, cloud-based image-guided therapy platform for cardiovascular and interventional radiology procedures. Its core offerings include Preview® for interactive 3D pre-operative planning and measurements, PEMS® for patient registry and longitudinal tracking, and SurveillAAAnce® for post-operative AAA surveillance, complemented by clinical trial imaging core lab services and curated R&D data services for medical device manufacturers.
Is Astute Imaging a public or private company?
Astute Imaging is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Astute Imaging founded?
Astute Imaging was founded in 2021. It employs 11 to 50 people.
Where is Astute Imaging based?
Astute Imaging is headquartered in Kirkland, United States, in the North America region.
How does Astute Imaging make money?
Four revenue lines are on record. SaaS Subscription Services are the primary driver. The others are imaging Core Lab Services, industry Case Planning Services and R&D Data Services.
Who are Astute Imaging's main competitors?
Direct peers on record are HeartFlow, Circle Cardiovascular Imaging and Pie Medical Imaging. Emerging players are RapidAI, Viz.ai, Aidoc, Median Technologies and icometrix. Broad incumbents are TeraRecon (ConcertAI) and Arterys (Tempus).
Does Astute Imaging have an API?
No public API is recorded for Astute Imaging.
What industry is Astute Imaging in?
Astute Imaging's product category is Medical Imaging Software. Its primary akta.pro industry code is HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage), with a secondary code of HLACALAD, Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic). Its NAICS code is 54151 and its SIC code is 3841.